US NIH (National Institutes of Health) in first stem cell deal:
This article was originally published in Clinica
Executive Summary
The National Institutes of Health (NIH) has signed the first international agreement involving the distribution of human stem cells. ES Cell International of Melbourne, Australia, has agreed to make its six existing stem cell lines available to NIH and non-profit institutions for a handling fee and will retain all commercial rights. NIH will retain its ownership to any new intellectual property that might arise. The stem cells meet the government's ethical criteria necessary in order to be used in federally-funded laboratories.